|
|
Volumn 31, Issue 6, 1997, Pages 787-788
|
|
Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIPALMITOYLPHOSPHATIDYLCHOLINE;
LUNG SURFACTANT;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST CONTROL;
DOSE RESPONSE;
DRUG EFFICACY;
HEALTH ECONOMICS;
HUMAN;
INFANT;
LETTER;
MAJOR CLINICAL STUDY;
NEWBORN;
NEWBORN DEATH;
PRIORITY JOURNAL;
RESPIRATORY DISTRESS SYNDROME;
SURVIVAL;
TREATMENT OUTCOME;
|
|
EID: 0030953130
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1177/106002809703100621 Document Type: Letter |
|
Times cited : (3)
|
|
References (7)
|
